Abivax (ABVX) Other Non-Current Assets (2021 - 2025)
Abivax (ABVX) posted quarterly Other Non-Current Assets of $6.2 million for Q4 2025, down 1.39% year-over-year from $6.3 million in Q4 2024, and up 591.06% quarter-over-quarter from $902516.8 in Q1 2025.
Abivax (ABVX) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Abivax's Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $6.2 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 1.39% year-over-year to $6.2 million; the TTM figure through Dec 2025 stood at $6.2 million (down 1.39% YoY), while the FY2025 annual figure was $6.2 million, down 1.39% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $6.2 million, up from $902516.8 in the prior quarter.
- The five-year high for Other Non-Current Assets was $13.8 million in Q4 2023, with the low at $902516.8 in Q1 2025.
- The 5-year median for Other Non-Current Assets is $6.2 million (2025), against an average of $6.0 million.
- The sharpest annual moves came in 2022 and 2024: Other Non-Current Assets soared 678.07% in 2022, then tumbled 54.32% in 2024.
- Abivax's Other Non-Current Assets stood at $1.5 million in 2021, then soared by 678.07% to $11.9 million in 2022, then gained by 15.93% to $13.8 million in 2023, then sank by 54.32% to $6.3 million in 2024, then declined by 1.39% to $6.2 million in 2025.
- Business Quant data shows ABVX's Other Non-Current Assets at $6.2 million in Q4 2025, $902516.8 in Q1 2025, and $6.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Abivax | 9.39 Bn | 9.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.24 Mn |
| Mar 31, 2025 | 902,516.85 |
| Dec 31, 2024 | 6.33 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Dec 31, 2023 | 13.85 Mn |
| Dec 31, 2022 | 11.95 Mn |
| Dec 31, 2021 | 1.54 Mn |